6307-78-4 Usage
Uses
Used in Organic Synthesis:
2,6-dimethyl-3-nitrobenzoyl chloride is used as a reagent in organic synthesis for the preparation of pharmaceuticals and other organic compounds. Its unique structure and functional groups make it a versatile building block in the creation of complex organic molecules.
Used in Chemical Intermediates:
2,6-dimethyl-3-nitrobenzoyl chloride serves as a key intermediate in the synthesis of various chemicals, including dyes, pigments, and agricultural products. Its ability to participate in a range of chemical reactions makes it indispensable in the production of these materials.
Used in Acylation Reactions:
2,6-dimethyl-3-nitrobenzoyl chloride is used as a powerful acylating agent for the modification of organic molecules. Its reactivity allows for the transfer of the acyl group to other molecules, facilitating the formation of new chemical entities with altered properties.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2,6-dimethyl-3-nitrobenzoyl chloride is used as a reagent for the synthesis of various drug compounds. Its role in the creation of new pharmaceuticals is crucial, as it can contribute to the development of novel therapeutic agents.
Safety Considerations:
It is important to handle 2,6-dimethyl-3-nitrobenzoyl chloride with care due to its potential toxicity and irritating properties to the skin, eyes, and respiratory system. Proper safety measures should be taken to minimize exposure and ensure the well-being of those working with 2,6-dimethyl-3-nitrobenzoyl chloride.
Check Digit Verification of cas no
The CAS Registry Mumber 6307-78-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,0 and 7 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 6307-78:
(6*6)+(5*3)+(4*0)+(3*7)+(2*7)+(1*8)=94
94 % 10 = 4
So 6307-78-4 is a valid CAS Registry Number.
6307-78-4Relevant academic research and scientific papers
Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: Synthesis, structure-activity relationships, and inhibition of in vivo T cell activation
DiMauro, Erin F.,Newcomb, John,Nunes, Joseph J.,Bemis, Jean E.,Boucher, Christina,Chai, Lilly,Chaffee, Stuart C.,Deak, Holly L.,Epstein, Linda F.,Faust, Ted,Gallant, Paul,Gore, Anu,Gu, Yan,Henkle, Brad,Hsieh, Faye,Huang, Xin,Kim, Joseph L.,Lee, Josie H.,Martin, Matthew W.,McGowan, David C.,Metz, Daniela,Mohn, Deanna,Morgenstern, Kurt A.,Oliveira-Dos-Santos, Antonio,Patel, Vinod F.,Powers, David,Rose, Paul E.,Schneider, Stephen,Tomlinson, Susan A.,Tudor, Yan-Yan,Turci, Susan M.,Welcher, Andrew,Zhao, Huilin,Zhu, Li,Zhu, Xiaotian
, p. 1681 - 1694 (2008/12/20)
The lymphocyte-specific kinase (Lck), a member of the Src family of cytoplasmic tyrosine kinases, is expressed in T cells and natural killer (NK) cells. Genetic evidence, including knockout mice and human mutations, demonstrates that Lck kinase activity i
